European Federation of Pharmaceutical Industries and Associations (EFPIA)
Lobbying costs:
WARNING: As this organisation lists one or more EP accredited lobbyists, it is highly improbable that its lobbying costs are lower than €10,000.
WARNING: The lobbying costs declared by this organisation are extraordinarily high and may therefore have been over-declared.
4,651,809€
Lobbyists declared: 9 FTE (25)
WARNING: The number of full time equivalent lobbyists declared by this organisation are extraordinarily high and may therefore have been over-declared.
Lobbyists with EP accreditation: 10
Meetings with European Commission: 76
Lobbying costs over the years:
European Federation of Pharmaceutical Industries and Associations (EFPIA)
Registration on EU Transparency Register
Website
Goals / Remit
EFPIA operates as the representative organisation of the research based pharmaceutical industry in Europe. The aim of the Federation, which has no profit-making purpose, is to promote pharmaceutical discovery and development in Europe and to promote a European regulatory environment, which facilitates innovative medicinal products to the market in order to improve human health worldwide.
In addition, EFPIA pursues a mainly scientific aim, ensuring and promoting the technological and economic development of the pharmaceutical industry in Europe. EFPIA’s activities extend to all matters of common interest to its members. In particular, it aims to foster an environment that encourages pharmaceutical research and development, manufacture in compliance with high quality standards, intellectual property protection and the introduction of regulatory requirements to allow patients rapid access to medicinal products.
EFPIA has developed Guidance for its members and it is available on its website.
Issues
Any health or pharmaceutical policy stemming from the European institutions, such as life sciences strategy, industrial policy, European Semester, Horizon Europe Research Programme, HTA policy, IP policy, One Health Approach to tackle AMR, pharmaceutical, orphan and paediatrics legislation, COVID-19 outbreak measures, etc. EFPIA also follows ongoing trade negotiations and legislative files when relevant to the innovative pharmaceutical industry (such as Water Framework Directive, Welfare of animals in scientific testing etc).
Address
8 Rue Mil Neuf Cents
Luxembourg L-2157,
Luxembourg
Tel: 32 26262555
Belgium office:
Rue du Trône 108
Brussels 1050,
Belgium
Tel: 32 26262555